Browse
Explore conditions, clinical trials, and the organisations running them.
Never miss a new study
Get alerted when new trials match your condition
Sign up free to track the conditions you care about and get a personal digest when new trials appear.
By submitting, you agree to our Terms of use
127005 trials found · Page 704 of 6351
-
New combo therapy aims to boost survival in esophageal cancer patients
Disease control Recruiting nowThe goal of this clinical trial is to learn if immunotherapy in combination with tumor draining lymph nodes-sparing radiotherapy (TDLN-sparing RT) and chemotherapy works to treat locally advanced esophageal squamous cell cancer in adults. Researchers will compare immunotherapy i…
Phase 3 • Sponsor: Fudan University • Aim: Disease control
Last updated Jun 27, 2026 08:08 UTC
-
Can a 15-Minute relaxation ritual tame cancer ICU symptoms?
Symptom relief CompletedThe benson Relaxation Technique (BRT), developed by Dr. Herbert Benson, is a method aimed at reducing stress and anxiety through a series of simple steps designed to elicit the "Relaxation Response." This response is a physiological state that counteracts the harmful effects of s…
Sponsor: Damanhour University • Aim: Symptom relief
Last updated Aug 28, 2026 00:00 UTC
-
Brain zaps for addiction: new study targets relapse with personalized implants
Disease control Recruiting nowSubstance use disorder (SUD) or addiction to drugs/alcohol is a devastating disease. Over 40,000 overdose deaths have happened in Canada since 2016, 1 in 5 Canadians will have a SUD, and 70% of those with SUD continue to relapse, showing that we urgently need new treatments. The …
Sponsor: Centre for Addiction and Mental Health • Aim: Disease control
Last updated Jun 27, 2026 12:25 UTC
-
New combo aims to keep myeloma in check after CAR t
Disease control Recruiting nowThe aim of this research study is to evaluate the efficacy of Elotuzumab and Iberdomide therapy post-Idecabtagene Vicleucel in participants with relapsed and refractory multiple myeloma. The names of the study drugs involved in this study are: * Iberdomide (a type of cereblon E…
Phase 1/2 • Sponsor: Omar Nadeem, MD • Aim: Disease control
Last updated Jun 27, 2026 08:03 UTC
-
Blood test may personalize chemo for colorectal cancer patients
Disease control Recruiting nowThe patient (T4N0 or low-risk stage III) will be randomly assigned to either the control group (FOLFOX/CAPOX for 3 months) or the intervention group (FOLFOX/CAPOX for 6 months or FOLFOX/CAPOX for 3 months followed by FOLFIRI/CAPIRI for 3 months) to receive adjuvant therapy. Venou…
Phase 2 • Sponsor: Fudan University • Aim: Disease control
Last updated Jun 27, 2026 12:28 UTC
-
Soy power: could natural compounds sharpen your mind?
Symptom relief CompletedIsoflavones (ISF) are naturally occurring compounds that can provide protective benefits for certain domains of cognitive function. Studies on the prevalence of cognitive decline and cancers in the Asian diet-eating areas of the world have investigated the effects of the ISFs and…
Sponsor: University of Reading • Aim: Symptom relief
Last updated Aug 05, 2026 00:00 UTC
-
Immunotherapy-Chemo cocktail shows promise for Tough-to-Treat throat cancer
Disease control Recruiting nowThis study aims to investigate toripalimab with chemotherapy in participants with nasopharyngeal cancer.
Phase 4 • Sponsor: Coherus Oncology, Inc. • Aim: Disease control
Last updated Aug 01, 2026 00:00 UTC
-
Weight loss after cancer: a new program aims to help survivors
Disease control CompletedThis study aims to conduct a feasibility trial to examine the feasibility and acceptability of conducting a randomized controlled trial that evaluates the effect of the weight management intervention on anthropometric measures (body weight and BMI), dietary quality, physical acti…
Sponsor: The University of Hong Kong • Aim: Disease control
Last updated Sep 02, 2026 00:00 UTC
-
Can a radioactive antibody light up hidden tumors?
Diagnosis Recruiting nowSoft Tissue Sarcoma (STS) is a cancer of soft tissues that often expresses Platelet-Derived Growth Factor Receptor (PDGFR)α, a potential therapeutic target. PDGFRα is also found in other advanced solid tumours. Olaratumab, a PDGFRα-targeted antibody, may be used to deliver radio…
Phase 1 • Sponsor: Telix Pharmaceuticals (Innovations) Pty Ltd • Aim: Diagnosis
Last updated Aug 16, 2026 00:00 UTC
-
New pill plus chemo shows promise for kids with tough cancers
Disease control Recruiting nowThe purpose of this study is to evaluate the investigational drug, silmitasertib (a pill taken by mouth), in combination with FDA approved drugs for solid tumors. An investigational drug is one that has not been approved by the U.S. Food \& Drug Administration (FDA), or any other…
Phase 1/2 • Sponsor: Milton S. Hershey Medical Center • Aim: Disease control
Last updated Sep 05, 2026 00:00 UTC
-
New drug combo aims to halt blinding eye disease
Disease control Recruiting nowThis study is researching experimental (study) drugs called pozelimab and cemdisiran. The study is focused on participants who have Geographic Atrophy (GA) caused by Age-related Macular Degeneration (AMD). Geographic atrophy is a medical term that refers to later-stage cases of A…
Phase 3 • Sponsor: Regeneron Pharmaceuticals • Aim: Disease control
Last updated Aug 27, 2026 00:00 UTC
-
New drug cocktail aims to outsmart resistant ovarian cancer
Disease control OngoingThe purpose of this study is to measure the effect and safety of treatment with tuvusertib combined with either niraparib or lartesertib in participants with epithelial ovarian cancer and to assess any differences between tuvusertib monotherapy and combination therapy. The partic…
Phase 2 • Sponsor: EMD Serono Research & Development Institute, Inc. • Aim: Disease control
Last updated Jun 27, 2026 13:01 UTC
-
Gene-Editing shot aims to slash cholesterol that drugs Can't touch
Disease control Recruiting nowVT-20101 is an Open-label, Phase 1b, Single-ascending dose study that will evaluate the safety of VERVE-201 administered to patients with Refractory Hyperlipidemia. VERVE-201 uses base-editing technology designed to inactivate the expression of the ANGPTL3 gene in the liver and …
Phase 1 • Sponsor: Verve Therapeutics, Inc. • Aim: Disease control
Last updated Jul 19, 2026 00:00 UTC
-
New drug cocktail targets tough ovarian cancer in japanese women
Disease control OngoingThis study will confirm the safety and efficacy of avutometinib in combination with defactinib in Japanese patients with recurrent Low-Grade Serous Ovarian Cancer (LGSOC)
Phase 2 • Sponsor: Verastem, Inc. • Aim: Disease control
Last updated Jun 27, 2026 08:04 UTC
-
New combo aims to boost lung cancer treatment
Disease control OngoingThis study will compare Valemetostat Tosylate Plus Pembrolizumab vs Pembrolizumab Alone in First-line NSCLC Without Actionable Genomic Alterations
Phase 1/2 • Sponsor: Daiichi Sankyo • Aim: Disease control
Last updated Jul 30, 2026 00:00 UTC
-
New pill plus chemo shows promise in early AML trial
Disease control OngoingThis single-armed study aims to investigate the safety and efficacy of sonrotoclax in combination with intensive chemotherapy in subjects with newly diagnosed AML. Subjects will be stratified based on the genetic risk classification of 2022 European LeukemiaNet (ELN) recommendati…
Phase 2 • Sponsor: Shanghai Jiao Tong University School of Medicine • Aim: Disease control
Last updated Jun 27, 2026 12:26 UTC
-
Can a new pill help fight obesity? a trial puts HRS-7535 to the test
Disease control CompletedThe study is being conducted to evaluate the safety, tolerability, pharmacokinetics, and pharmacodynamics of multiple doses of HRS-7535 tablet in obese subjects.
Phase 1/2 • Sponsor: Shandong Suncadia Medicine Co., Ltd. • Aim: Disease control
Last updated Aug 26, 2026 00:00 UTC
-
Immune cell therapy takes on tough endometrial cancer
Disease control Recruiting nowThe purpose of this study is to investigate the efficacy and safety of the lifileucel regimen in participants with previously treated endometrial cancer.
Phase 2 • Sponsor: Iovance Biotherapeutics, Inc. • Aim: Disease control
Last updated Jun 27, 2026 07:56 UTC
-
Smart app tailors virus drug for vulnerable kids
Disease control Recruiting nowThis study is being conducted at seven major children's hospitals in Australia and New Zealand to test a new approach for treating a virus, called cytomegalovirus in children with weakened immune systems. The researchers want to find out if using a web app to customise the dose o…
Phase 2 • Sponsor: Murdoch Childrens Research Institute • Aim: Disease control
Last updated Jun 27, 2026 12:05 UTC
-
A Needle-Free future for kidney diagnosis?
Knowledge-focused Recruiting nowDevelopment of renal fibrosis is the irreversible culmination of various renal diseases and independently predicts adverse outcomes. Currently renal fibrosis can only be diagnosed by performing a renal biopsy. The procedure is invasive and is limited by sampling bias. In recent …
Sponsor: Patrick Schjelderup • Aim: Knowledge-focused
Last updated Aug 29, 2026 00:00 UTC